ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multi Cancer Screening Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5G14413
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Multi Cancer Screening Market Research Report 2023
BUY CHAPTERS

Global Multi Cancer Screening Market Research Report 2025

Code: QYRE-Auto-5G14413
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Guardant Health
GRAIL
Burning Rock
Thermo Fisher Scientific
Exact Sciences Corporation
Fulgent Genetics
Agilent Technologies
Atara Biotherapeutics
Konica Minolta
Tempus
Myriad Genetics
Laboratory Corporation
Genecast Biotechnology

Multi Cancer Screening Market

The global market for Multi Cancer Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Multi Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Multi Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Multi Cancer Screening in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Multi Cancer Screening include Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific, Exact Sciences Corporation, Fulgent Genetics, Genecast Biotechnology, Agilent Technologies, Atara Biotherapeutics, Konica Minolta, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multi Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Screening.
The Multi Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multi Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Multi Cancer Screening Market Report

Report Metric Details
Report Name Multi Cancer Screening Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific, Exact Sciences Corporation, Fulgent Genetics, Genecast Biotechnology, Agilent Technologies, Atara Biotherapeutics, Konica Minolta, Tempus, Myriad Genetics, Laboratory Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Multi Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Multi Cancer Screening Market report?

Ans: The main players in the Multi Cancer Screening Market are Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific, Exact Sciences Corporation, Fulgent Genetics, Genecast Biotechnology, Agilent Technologies, Atara Biotherapeutics, Konica Minolta, Tempus, Myriad Genetics, Laboratory Corporation

What are the Application segmentation covered in the Multi Cancer Screening Market report?

Ans: The Applications covered in the Multi Cancer Screening Market report are Hospitals, Clinic

What are the Type segmentation covered in the Multi Cancer Screening Market report?

Ans: The Types covered in the Multi Cancer Screening Market report are Laboratory Developed Tests (LDTs), In-Vitro Diagnostics (IVDs)

Recommended Reports

Cancer Diagnostics

Cancer Therapies

Cancer Screening

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi Cancer Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Laboratory Developed Tests (LDTs)
1.2.3 In-Vitro Diagnostics (IVDs)
1.3 Market by Application
1.3.1 Global Multi Cancer Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi Cancer Screening Market Perspective (2020-2031)
2.2 Global Multi Cancer Screening Growth Trends by Region
2.2.1 Global Multi Cancer Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multi Cancer Screening Historic Market Size by Region (2020-2025)
2.2.3 Multi Cancer Screening Forecasted Market Size by Region (2026-2031)
2.3 Multi Cancer Screening Market Dynamics
2.3.1 Multi Cancer Screening Industry Trends
2.3.2 Multi Cancer Screening Market Drivers
2.3.3 Multi Cancer Screening Market Challenges
2.3.4 Multi Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi Cancer Screening Players by Revenue
3.1.1 Global Top Multi Cancer Screening Players by Revenue (2020-2025)
3.1.2 Global Multi Cancer Screening Revenue Market Share by Players (2020-2025)
3.2 Global Multi Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multi Cancer Screening Revenue
3.4 Global Multi Cancer Screening Market Concentration Ratio
3.4.1 Global Multi Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Screening Revenue in 2024
3.5 Global Key Players of Multi Cancer Screening Head office and Area Served
3.6 Global Key Players of Multi Cancer Screening, Product and Application
3.7 Global Key Players of Multi Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi Cancer Screening Breakdown Data by Type
4.1 Global Multi Cancer Screening Historic Market Size by Type (2020-2025)
4.2 Global Multi Cancer Screening Forecasted Market Size by Type (2026-2031)
5 Multi Cancer Screening Breakdown Data by Application
5.1 Global Multi Cancer Screening Historic Market Size by Application (2020-2025)
5.2 Global Multi Cancer Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multi Cancer Screening Market Size (2020-2031)
6.2 North America Multi Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multi Cancer Screening Market Size by Country (2020-2025)
6.4 North America Multi Cancer Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi Cancer Screening Market Size (2020-2031)
7.2 Europe Multi Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multi Cancer Screening Market Size by Country (2020-2025)
7.4 Europe Multi Cancer Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi Cancer Screening Market Size (2020-2031)
8.2 Asia-Pacific Multi Cancer Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multi Cancer Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Multi Cancer Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi Cancer Screening Market Size (2020-2031)
9.2 Latin America Multi Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multi Cancer Screening Market Size by Country (2020-2025)
9.4 Latin America Multi Cancer Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi Cancer Screening Market Size (2020-2031)
10.2 Middle East & Africa Multi Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multi Cancer Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Multi Cancer Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Multi Cancer Screening Introduction
11.1.4 Guardant Health Revenue in Multi Cancer Screening Business (2020-2025)
11.1.5 Guardant Health Recent Development
11.2 GRAIL
11.2.1 GRAIL Company Details
11.2.2 GRAIL Business Overview
11.2.3 GRAIL Multi Cancer Screening Introduction
11.2.4 GRAIL Revenue in Multi Cancer Screening Business (2020-2025)
11.2.5 GRAIL Recent Development
11.3 Burning Rock
11.3.1 Burning Rock Company Details
11.3.2 Burning Rock Business Overview
11.3.3 Burning Rock Multi Cancer Screening Introduction
11.3.4 Burning Rock Revenue in Multi Cancer Screening Business (2020-2025)
11.3.5 Burning Rock Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Multi Cancer Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Exact Sciences Corporation
11.5.1 Exact Sciences Corporation Company Details
11.5.2 Exact Sciences Corporation Business Overview
11.5.3 Exact Sciences Corporation Multi Cancer Screening Introduction
11.5.4 Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2020-2025)
11.5.5 Exact Sciences Corporation Recent Development
11.6 Fulgent Genetics
11.6.1 Fulgent Genetics Company Details
11.6.2 Fulgent Genetics Business Overview
11.6.3 Fulgent Genetics Multi Cancer Screening Introduction
11.6.4 Fulgent Genetics Revenue in Multi Cancer Screening Business (2020-2025)
11.6.5 Fulgent Genetics Recent Development
11.7 Genecast Biotechnology
11.7.1 Genecast Biotechnology Company Details
11.7.2 Genecast Biotechnology Business Overview
11.7.3 Genecast Biotechnology Multi Cancer Screening Introduction
11.7.4 Genecast Biotechnology Revenue in Multi Cancer Screening Business (2020-2025)
11.7.5 Genecast Biotechnology Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Multi Cancer Screening Introduction
11.8.4 Agilent Technologies Revenue in Multi Cancer Screening Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Multi Cancer Screening Introduction
11.9.4 Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2020-2025)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Konica Minolta
11.10.1 Konica Minolta Company Details
11.10.2 Konica Minolta Business Overview
11.10.3 Konica Minolta Multi Cancer Screening Introduction
11.10.4 Konica Minolta Revenue in Multi Cancer Screening Business (2020-2025)
11.10.5 Konica Minolta Recent Development
11.11 Tempus
11.11.1 Tempus Company Details
11.11.2 Tempus Business Overview
11.11.3 Tempus Multi Cancer Screening Introduction
11.11.4 Tempus Revenue in Multi Cancer Screening Business (2020-2025)
11.11.5 Tempus Recent Development
11.12 Myriad Genetics
11.12.1 Myriad Genetics Company Details
11.12.2 Myriad Genetics Business Overview
11.12.3 Myriad Genetics Multi Cancer Screening Introduction
11.12.4 Myriad Genetics Revenue in Multi Cancer Screening Business (2020-2025)
11.12.5 Myriad Genetics Recent Development
11.13 Laboratory Corporation
11.13.1 Laboratory Corporation Company Details
11.13.2 Laboratory Corporation Business Overview
11.13.3 Laboratory Corporation Multi Cancer Screening Introduction
11.13.4 Laboratory Corporation Revenue in Multi Cancer Screening Business (2020-2025)
11.13.5 Laboratory Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Guardant Health
GRAIL
Burning Rock
Thermo Fisher Scientific
Exact Sciences Corporation
Fulgent Genetics
Agilent Technologies
Atara Biotherapeutics
Konica Minolta
Tempus
Myriad Genetics
Laboratory Corporation
Genecast Biotechnology
List of Tables
 Table 1. Global Multi Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Laboratory Developed Tests (LDTs)
 Table 3. Key Players of In-Vitro Diagnostics (IVDs)
 Table 4. Global Multi Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Multi Cancer Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Multi Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Multi Cancer Screening Market Share by Region (2020-2025)
 Table 8. Global Multi Cancer Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Multi Cancer Screening Market Share by Region (2026-2031)
 Table 10. Multi Cancer Screening Market Trends
 Table 11. Multi Cancer Screening Market Drivers
 Table 12. Multi Cancer Screening Market Challenges
 Table 13. Multi Cancer Screening Market Restraints
 Table 14. Global Multi Cancer Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Multi Cancer Screening Market Share by Players (2020-2025)
 Table 16. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2024)
 Table 17. Ranking of Global Top Multi Cancer Screening Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Multi Cancer Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Multi Cancer Screening, Headquarters and Area Served
 Table 20. Global Key Players of Multi Cancer Screening, Product and Application
 Table 21. Global Key Players of Multi Cancer Screening, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Multi Cancer Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Multi Cancer Screening Revenue Market Share by Type (2020-2025)
 Table 25. Global Multi Cancer Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Multi Cancer Screening Revenue Market Share by Type (2026-2031)
 Table 27. Global Multi Cancer Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Multi Cancer Screening Revenue Market Share by Application (2020-2025)
 Table 29. Global Multi Cancer Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Multi Cancer Screening Revenue Market Share by Application (2026-2031)
 Table 31. North America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Multi Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Multi Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Multi Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Multi Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Multi Cancer Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Multi Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Multi Cancer Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Multi Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Multi Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Multi Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Multi Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Multi Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Guardant Health Company Details
 Table 47. Guardant Health Business Overview
 Table 48. Guardant Health Multi Cancer Screening Product
 Table 49. Guardant Health Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 50. Guardant Health Recent Development
 Table 51. GRAIL Company Details
 Table 52. GRAIL Business Overview
 Table 53. GRAIL Multi Cancer Screening Product
 Table 54. GRAIL Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 55. GRAIL Recent Development
 Table 56. Burning Rock Company Details
 Table 57. Burning Rock Business Overview
 Table 58. Burning Rock Multi Cancer Screening Product
 Table 59. Burning Rock Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 60. Burning Rock Recent Development
 Table 61. Thermo Fisher Scientific Company Details
 Table 62. Thermo Fisher Scientific Business Overview
 Table 63. Thermo Fisher Scientific Multi Cancer Screening Product
 Table 64. Thermo Fisher Scientific Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Recent Development
 Table 66. Exact Sciences Corporation Company Details
 Table 67. Exact Sciences Corporation Business Overview
 Table 68. Exact Sciences Corporation Multi Cancer Screening Product
 Table 69. Exact Sciences Corporation Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 70. Exact Sciences Corporation Recent Development
 Table 71. Fulgent Genetics Company Details
 Table 72. Fulgent Genetics Business Overview
 Table 73. Fulgent Genetics Multi Cancer Screening Product
 Table 74. Fulgent Genetics Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 75. Fulgent Genetics Recent Development
 Table 76. Genecast Biotechnology Company Details
 Table 77. Genecast Biotechnology Business Overview
 Table 78. Genecast Biotechnology Multi Cancer Screening Product
 Table 79. Genecast Biotechnology Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 80. Genecast Biotechnology Recent Development
 Table 81. Agilent Technologies Company Details
 Table 82. Agilent Technologies Business Overview
 Table 83. Agilent Technologies Multi Cancer Screening Product
 Table 84. Agilent Technologies Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 85. Agilent Technologies Recent Development
 Table 86. Atara Biotherapeutics Company Details
 Table 87. Atara Biotherapeutics Business Overview
 Table 88. Atara Biotherapeutics Multi Cancer Screening Product
 Table 89. Atara Biotherapeutics Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 90. Atara Biotherapeutics Recent Development
 Table 91. Konica Minolta Company Details
 Table 92. Konica Minolta Business Overview
 Table 93. Konica Minolta Multi Cancer Screening Product
 Table 94. Konica Minolta Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 95. Konica Minolta Recent Development
 Table 96. Tempus Company Details
 Table 97. Tempus Business Overview
 Table 98. Tempus Multi Cancer Screening Product
 Table 99. Tempus Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 100. Tempus Recent Development
 Table 101. Myriad Genetics Company Details
 Table 102. Myriad Genetics Business Overview
 Table 103. Myriad Genetics Multi Cancer Screening Product
 Table 104. Myriad Genetics Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 105. Myriad Genetics Recent Development
 Table 106. Laboratory Corporation Company Details
 Table 107. Laboratory Corporation Business Overview
 Table 108. Laboratory Corporation Multi Cancer Screening Product
 Table 109. Laboratory Corporation Revenue in Multi Cancer Screening Business (2020-2025) & (US$ Million)
 Table 110. Laboratory Corporation Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Multi Cancer Screening Picture
 Figure 2. Global Multi Cancer Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Multi Cancer Screening Market Share by Type: 2024 VS 2031
 Figure 4. Laboratory Developed Tests (LDTs) Features
 Figure 5. In-Vitro Diagnostics (IVDs) Features
 Figure 6. Global Multi Cancer Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Multi Cancer Screening Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Multi Cancer Screening Report Years Considered
 Figure 11. Global Multi Cancer Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Multi Cancer Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Multi Cancer Screening Market Share by Region: 2024 VS 2031
 Figure 14. Global Multi Cancer Screening Market Share by Players in 2024
 Figure 15. Global Top Multi Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Screening as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Multi Cancer Screening Revenue in 2024
 Figure 17. North America Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Multi Cancer Screening Market Share by Country (2020-2031)
 Figure 19. United States Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Multi Cancer Screening Market Share by Country (2020-2031)
 Figure 23. Germany Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Multi Cancer Screening Market Share by Region (2020-2031)
 Figure 31. China Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Multi Cancer Screening Market Share by Country (2020-2031)
 Figure 39. Mexico Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Multi Cancer Screening Market Share by Country (2020-2031)
 Figure 43. Turkey Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Multi Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Guardant Health Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 47. GRAIL Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 48. Burning Rock Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 50. Exact Sciences Corporation Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 51. Fulgent Genetics Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 52. Genecast Biotechnology Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 53. Agilent Technologies Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 54. Atara Biotherapeutics Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 55. Konica Minolta Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 56. Tempus Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 57. Myriad Genetics Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 58. Laboratory Corporation Revenue Growth Rate in Multi Cancer Screening Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Multi Cancer Early Detection Market Research Report 2025
Global Cancer Screening Technology Market Research Report 2024
Global Mammography Screening Market Research Report 2024
Global Cervical Cancer Screening Service Market Research Report 2024
Global Lung Cancer Screening Software Market Research Report 2024
Global Medical Screen Market Research Report 2024
Global Non Invasive Colon Cancer Screening Market Research Report 2024
Global Cervical Screening Market Research Report 2024
Global Cancer Insurance Market Research Report 2024
Global Point of care Cancer Screening Market Research Report 2025
Global Gynecological Cancer Screening Device Market Research Report 2024
Global Multi Screen Advertising Market Research Report 2024
Global Portable Cancer Screening Devices Market Research Report 2024
Global Cancer Cell Media Market Research Report 2024
Global Cancer Oncology Testing Market Research Report 2024
Global Regular Health Screening Services Market Research Report 2024
Global Diabetes Screening Market Research Report 2024
Global AML Screening Market Research Report 2024
Global In Vitro Cancer Screening Tests Kits Market Research Report 2024
Global Multi screen Video Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions